Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
39.2 /100
Rank 98 out of 131 Industries -
Advance/Decline
16/6
-
No. of Companies22
-
Avg. Market Cap4,255
-
Price to Earning Ratio32.51
-
Price to Earning Growth Ratio0.16
-
Price to Book Ratio10.67
-
Return on Equity17.05
-
Return on Capital Employed-
-
Return on Assets15.10
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %90.32 %
-
Net Profit Growth Qtr YoY %4.04 %
-
Net Profit Growth Qtr QoQ %5.85 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc |
|
411.5
|
22.5
|
L
 1.2%
H
22.1
22.9
|
L
 9.9%
H
20.5
22.9
|
L
 13%
H
18.9
22.9
|
L
 7.0%
H
18.5
22.9
|
L
 -34.5%
H
18.5
38.3
|
L
 -60.4%
H
18.5
69.6
|
L
 -73.7%
H
18.5
107.9
|
L
 -62.8%
H
18.5
138.0
|
| Argen X SE (ADR) |
|
51,178.8
|
827.0
|
L
 1.3%
H
816.3
827.6
|
L
 3.5%
H
781.1
827.6
|
L
 -3.3%
H
770.7
860.6
|
L
 -0.9%
H
749.8
934.6
|
L
 27.8%
H
510.1
934.6
|
L
 111.4%
H
327.7
934.6
|
L
 162.3%
H
248.2
934.6
|
L
H
17.3
934.6
|
| Biondvax Pharma Ltd (ADR) |
|
-
|
0.9
|
L
 -1.2%
H
0.8
0.9
|
L
 -11.5%
H
0.8
1.0
|
L
 7.6%
H
0.6
1.0
|
L
 -43.7%
H
0.6
1.6
|
L
 -70.8%
H
0.6
6.2
|
L
 -69.1%
H
0.6
6.2
|
L
 -98.6%
H
0.6
99
|
L
 -97.7%
H
0.6
620
|
| Niagen Bioscience Inc |
|
501.2
|
6.3
|
L
 1.3%
H
6.2
6.4
|
L
 -0.5%
H
6.0
6.4
|
L
 -3.7%
H
6.0
7.1
|
L
 -16.4%
H
6.0
8.0
|
L
 3.1%
H
5.3
14.7
|
L
 241.3%
H
1.3
14.7
|
L
 30.8%
H
1.2
23.7
|
L
 63.5%
H
1.2
23.7
|
| Cronos Grp Inc |
|
1,026.2
|
2.7
|
L
 2.7%
H
2.6
2.7
|
L
 1.9%
H
2.5
2.7
|
L
 -9.5%
H
2.5
3.0
|
L
 7.2%
H
2.3
3.4
|
L
 37.4%
H
1.6
3.4
|
L
 7.2%
H
1.6
3.4
|
L
 -75.0%
H
1.6
15.8
|
L
H
0.2
25.1
|
| Enveric Biosciences Inc |
|
4.4
|
4.3
|
L
 2.2%
H
4.1
4.3
|
L
 2.7%
H
3.8
4.3
|
L
 -16.1%
H
3.5
5.3
|
L
 -47.7%
H
3.5
13.3
|
L
 -93%
H
3.5
63
|
L
 -99.2%
H
3.5
1256.4
|
L
 -100.0%
H
3.5
63000
|
L
 -100.0%
H
3.5
12150000
|
| Flora Growth Corp |
|
7.1
|
6.8
|
L
 0.7%
H
6.7
7.2
|
L
 8.3%
H
6.1
7.4
|
L
 -6.7%
H
5.9
8.9
|
L
 -60.4%
H
5.9
17.5
|
L
 -81.3%
H
5.9
47
|
L
 -96.6%
H
5.9
464.3
|
L
H
5.9
16731
|
L
H
5.9
16731
|
| IM Cannabis Corp |
|
7.1
|
1.4
|
L
 -1.5%
H
1.3
1.5
|
L
 -4.2%
H
1.3
1.5
|
L
 -12.8%
H
1.3
1.6
|
L
 -30.6%
H
0.9
2.6
|
L
 -42.9%
H
0.9
7.1
|
L
 -82.4%
H
0.4
11.0
|
L
 -99.7%
H
0.4
697.8
|
L
H
0.4
697.8
|
| Lifevantage Corp |
|
75.8
|
6.0
|
L
 4.7%
H
5.7
6.0
|
L
 -2.1%
H
5.5
6.5
|
L
 -3.7%
H
5.5
6.8
|
L
 -30.8%
H
5.5
9
|
L
 -76.1%
H
5.5
25.4
|
L
 56.7%
H
3.0
27.4
|
L
 -35.5%
H
3.0
27.4
|
L
 -24.0%
H
2.9
27.4
|
| Mannatech Inc |
|
14.4
|
7.6
|
L
 2.2%
H
7.5
7.6
|
L
 -0.5%
H
7
9.5
|
L
 -6.8%
H
6.9
9.5
|
L
 -21.9%
H
6.9
12.5
|
L
 -33.3%
H
6.9
16.5
|
L
 -54.3%
H
6.8
21.2
|
L
 -60.3%
H
6.8
49.1
|
L
 -55.4%
H
6.5
49.1
|
| Natural Alternatives Intl Inc |
|
26.7
|
4.3
|
L
 -1.6%
H
4.3
4.5
|
L
 -9.1%
H
4.3
4.8
|
L
 34.6%
H
3.1
5.0
|
L
 64.3%
H
2.6
5.0
|
L
 2.9%
H
2.6
5.0
|
L
 -51.0%
H
2.6
9.8
|
L
 -66.7%
H
2.6
19.9
|
L
 -39.7%
H
2.6
19.9
|
| Nature`s Sunshine Products Inc |
|
429.3
|
24.5
|
L
 1.3%
H
24
24.6
|
L
 10.3%
H
22.0
24.6
|
L
 10.3%
H
20.9
24.6
|
L
 70.9%
H
13.0
24.6
|
L
 66.3%
H
11.0
24.6
|
L
 159.1%
H
8.3
24.6
|
L
 58.3%
H
7.9
24.6
|
L
 177.6%
H
5.5
24.6
|
| Paranovus Entertainment Tech Ltd (Class A) |
|
6.9
|
1.9
|
L
 9.0%
H
1.7
1.9
|
L
 9.0%
H
1.7
2.1
|
L
 -13%
H
1.4
3.0
|
L
 -96.9%
H
1.4
120
|
L
 -98.6%
H
1.4
150
|
L
 -99.6%
H
1.4
670
|
L
 -100.0%
H
1.4
5160
|
L
H
1.4
12200
|
| PharmaCyte Biotech Inc |
|
9.1
|
0.9
|
L
 2.3%
H
0.9
0.9
|
L
 -2.2%
H
0.8
1
|
L
 4.7%
H
0.7
1
|
L
 -8.2%
H
0.6
1.5
|
L
 -46.1%
H
0.6
1.9
|
L
 -69.5%
H
0.6
3.2
|
L
 -96.5%
H
0.6
55.5
|
L
 -99.1%
H
0.6
253.4
|
| AIxCrypto Holdings Inc |
|
11.0
|
2.1
|
L
 0.9%
H
2.1
2.3
|
L
 -14.7%
H
2.1
2.6
|
L
 -21.9%
H
2.1
3.0
|
L
 -44.0%
H
2.1
6.0
|
L
 -48.8%
H
1.6
8.8
|
L
 -96.6%
H
0.1
74
|
L
 -99.9%
H
0.1
2217
|
L
 -100.0%
H
0.1
468750
|
| Revolution Medicines Inc |
|
22,968.3
|
118.8
|
L
 1.1%
H
116.6
120.5
|
L
 -2.0%
H
114.0
124.5
|
L
 50.8%
H
76.3
124.5
|
L
 122.1%
H
52.5
124.5
|
L
 195.8%
H
29.2
124.5
|
L
 331.7%
H
15.5
124.5
|
L
 174.7%
H
14.1
124.5
|
L
H
14.1
124.5
|
| Upexi Inc |
|
125.2
|
2.0
|
L
 -5.7%
H
2.0
2.2
|
L
 -19.5%
H
2.0
2.5
|
L
 -4.8%
H
1.7
2.5
|
L
 -61.1%
H
1.7
5.3
|
L
 -37.7%
H
1.7
22.5
|
L
 -97.0%
H
1.7
98.8
|
L
H
1.7
187.4
|
L
H
1.7
187.4
|
| Scinai Immunotherapeutics Ltd (ADR) |
|
2.8
|
0.8
|
L
 -3.5%
H
0.8
0.9
|
L
 -14.6%
H
0.8
1.0
|
L
 3.8%
H
0.6
1.0
|
L
 -45.7%
H
0.6
1.6
|
L
 -77.0%
H
0.6
6.2
|
L
 -97.0%
H
0.6
46.9
|
L
 -99.9%
H
0.6
722
|
L
 -99.8%
H
0.6
6200
|
| FitLife Brands Inc |
|
154.8
|
16.5
|
L
 -0.8%
H
16.2
16.9
|
L
 8.1%
H
15.3
16.9
|
L
 -2.4%
H
15.0
17.1
|
L
 -8.6%
H
15.0
20.0
|
L
 -49.4%
H
9.8
33.5
|
L
 -0.4%
H
9.8
35.5
|
L
 -0.4%
H
9.8
35.5
|
L
 -0.4%
H
9.8
35.5
|
| Abivax (ADR) |
|
9,698.1
|
123.6
|
L
 3.0%
H
117.3
123.7
|
L
 -1.1%
H
113.4
130.1
|
L
 7.6%
H
109.0
148.8
|
L
 34.9%
H
87.6
148.8
|
L
 1840.8%
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
| Synergy CHC Corp |
|
21.4
|
1.9
|
L
 3.3%
H
1.9
2.0
|
L
 4.4%
H
1.7
2.0
|
L
 3.8%
H
1.7
2.0
|
L
 -24.9%
H
1.7
2.9
|
L
 -53.2%
H
1.3
4.5
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
| iBio Inc |
|
53.7
|
2.4
|
L
 6.7%
H
2.2
2.4
|
L
 -4.0%
H
2.1
2.5
|
L
 20.7%
H
1.7
2.9
|
L
 115.3%
H
1.0
3.8
|
L
 198.8%
H
0.6
3.8
|
L
 198.8%
H
0.6
3.8
|
L
 198.8%
H
0.6
3.8
|
L
 198.8%
H
0.6
3.8
|